Globus Medical, Inc. (NYSE: GMED) will release its first-quarter 2025 financial results on Thursday, May 8, 2025, after ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...

In the preceding three months, 5 analysts have released ratings for Globus Medical GMED, presenting a wide array of perspectives from bullish to bearish. The table below summarizes their recent ...

Globus Medical GMED +0.38% Get Free Report has outperformed the market over the past 10 years by 1.4% on an annualized basis ...

The acquisition expands Globus Medical’s reach in the musculoskeletal market and the opportunity to add to its product portfolio. The deal was first announced in February, and Nevro was valued ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Globus Medical (GMED), which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider. This medical device company has seen a nice streak of beating earnings ...